Search Results 101-110 of 17227 for diarrea
The only drug currently approved for IBS-D is alosetron, a 5-HT3 antagonist that may relieve abdominal pain and slow colonic and small bowel transit. Alosetron ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...
This illness is caused by bacteria that spreads in food. It can be very serious for some people. Learn about symptoms, treatment and tips to prevent it.
Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric Neuroscience Program ...
About this study. To compare with a randomized trial (n=15 per treatment group), effects of colesevelam and placebo treatment, on colonic transit, ...
There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
Imperforate Anus, also known as anal atresia, is a rare birth defect. Unable to pass stool through the gastrointestinal tract, this condition can result in ...
Lifestyle changes can make a big difference when it comes to managing this common GI disorder. Learn more about symptoms, diagnosis and how to handle ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!